SIZE XSSIZE SMSIZE MDSIZE LG

Opioid Prescribing in Cancer Patients: Building Trust

October 25, 2018
7:00–8:00 pm EST / 6:00–7:00 pm CDT

Register Now

Statement of Need/Activity Purpose

Recent guidelines for both cancer and non-cancer patients recommend incorporating risk assessment tools in the clinician’s pain assessment process. This is a new practice recommendation and a literature review is needed to review the risk assessment and management tools to be used in the cancer population. In addition, clinicians require guidance to interpret the results of these risk management tools and how the results impact treatment plans.

Learning Objectives

  • State the components of a comprehensive pain assessment for cancer patients based on the current guidelines.
  • Review available opioid risk assessment tools and the evidence for use in cancer patients.
  • Given a patient case, interpret an opioid risk assessment result and develop a pain management treatment plan based on the result.

Speaker

HOPA webinar education speaker diana berescu

Dr. Diana Berescu, PharmD BCPS
Pain and Palliative Care Pharmacy Specialist
University of Maryland Medical Center
Baltimore, MD

Dr. Diana Berescu received her Doctor of Pharmacy from the University of Toronto and completed her PGY1 in Pharmacy Practice at Howard County General Hospital. She recently completed her PGY2 Pain and Palliative Care Pharmacy Resident at The Johns Hopkins Hospital where she gained valuable experience in acute and chronic pain management therapies in both the inpatient and outpatient setting. She recently introduced a new member to her family and is on leave with her new son. She will be starting at the University of Maryland Medical Center as the Pain and Palliative Care Pharmacy Specialist in the coming year. Her interests include the safe and effective use of non-opioid medications. As well, she is particularly interested in patient education about pain management and the development of trust in the patient-provider relationship.

Disclosures:

None

Target Audience

This activity is intended for Hematology/Oncology pharmacists. This activity has been approved for 1.00 contact hours (.10CEUs) under the ACPE universal activity number # 0465-0000-18-075-L04-P.

Activity Type:

Knowledge

Registration Fees:

HOPA Member ‒ $20
Nonmember ‒ $40

Accreditation Statement:

logo acpeThe Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. A statement of credit will be issued only upon completion of the post-activity evaluation form and post-test.

Handouts for the webinar will be emailed to you 1-2 business days prior to the event.

If you have questions about this Opioid Prescribing in Cancer Patients: Building Trust Webinar, please contact Bridget Brown, Education Coordinator at This email address is being protected from spambots. You need JavaScript enabled to view it..

 

xs
sm
md
lg